Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.94 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | CA2 | P00918 | 4/20 | 0.56 |
| ▸ | CA12 | O43570 | 3/20 | 0.56 |
| ▸ | CA9 | Q16790 | 3/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.56 |
| ▸ | NT5E | P21589 | 1/20 | 0.56 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenolsulfonic Acid SCHEMBL32135 | 1.00 | LMNA (0.94) | LMNAALDH1A1CA2CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL1115419 | 0.97 | LMNA (0.90) | LMNAALDH1A1CA2CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL10622999 | 0.97 | LMNA (1.00) | LMNAALDH1A1CA2CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL18275 | 0.97 | LMNA (1.00) | LMNAALDH1A1CA2CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL29965481 | 0.97 | LMNA (1.00) | LMNAALDH1A1CA2CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL1866289 | 0.94 | LMNA (0.94) | LMNAALDH1A1CA2CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL1470056 | 0.94 | LMNA (0.94) | LMNAALDH1A1CA2CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL20815893 | 0.94 | LMNA (0.94) | LMNAALDH1A1CA2CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL560246 | 0.94 | LMNA (0.94) | LMNAALDH1A1CA2CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL9682015 | 0.94 | LMNA (0.94) | LMNAALDH1A1CA2CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 912 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250332079-A1 | TOPICAL SUNSCREEN | CONCEPT MATRIX SOLUTIONS | 2025-10-30 | — | — | US | claimed |
| US-12350356-B2 | Topical sunscreen | CONCEPT MATRIX SOLUTIONS | 2025-07-08 | — | — | US | claimed |
| EP-4301323-B1 | ORAL CARE COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2025-01-29 | — | — | EP | claimed |
| EP-4301323-A1 | ORAL CARE COMPOSITION | Unilever IP Holdings B.V. (NL) | 2024-01-10 | — | — | EP | claimed |
| CN-115737481-A | Sweat-inhibiting, sterilizing and deodorizing composition | 深圳市理然化妆品有限公司 | 2023-03-07 | — | — | CN | claimed |
| WO-2022184877-A2 | ORAL CARE COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2022-09-09 | — | — | WO | claimed |
| WO-2022184876-A1 | ORAL CARE COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2022-09-09 | — | — | WO | claimed |
| CN-114642605-A | Anti-dandruff shampoo containing compound zinc component and preparation method thereof | 广东柏亚化妆品有限公司 | 2022-06-21 | — | — | CN | claimed |
| US-20210093529-A1 | TOPICAL SUNSCREEN | CONCEPT MATRIX SOLUTIONS | 2021-04-01 | — | — | US | claimed |
| US-20180147140-A1 | Treatment and Prevention of ENT Infections | Finn, Darryl Thomas (US) | 2018-05-31 | — | — | US | claimed |
| US-5965137-A | Insect repellent composition and method for inhibiting the transmission and treatment of symptoms of vector-borne diseases | ADVANCED MEDICAL INSTRUMENTS (US) | 1999-10-12 | — | — | US | claimed |
| WO-1999038474-A1 | DEODORANT COMPOSITION CONTAINING D-AMINO ACID | THE GILLETTE COMPANY (US) | 1999-08-05 | — | — | WO | claimed |
| US-5875799-A | Therapeutic dental floss for treating systemic diseases | ADVANCED MEDICAL INSTRUMENTS, INC. (US) | 1999-03-02 | — | — | US | claimed |
| US-5875798-A | Therapeutic toothpick for treating oral and systemic diseases | ADVANCED MEDICAL INSTRUMENTS, INC. (US) | 1999-03-02 | — | — | US | claimed |
| EP-0813394-A1 | GUM TISSUE RETRACTION DEVICE AND METHOD | CENTRIX, INC. (US) | 1997-12-29 | — | — | EP | claimed |
| US-5676543-A | Gum tissue retraction device and method | CENTRIX, INC. (US) | 1997-10-14 | — | — | US | claimed |
| WO-1996027342-A1 | GUM TISSUE RETRACTION DEVICE AND METHOD | CENTRIX, INC. (US) | 1996-09-12 | — | — | WO | claimed |
| US-4152418-A | Zinc and enzyme mouthwash and mouthwash concentrate for reducing dental plaque and calculus formation | LEVER BROTHERS COMPANY (US) | 1979-05-01 | — | — | US | claimed |
| US-4121013-A | 3,5-SUBSTITUTED SALICYLIC ACID, ZINC COMPOUND, AMMONIUM HYDROXIDE, COATINGS, SENSITIZED FOR COLOR DEVELOPMENT | NCR CORPORATION (US) | 1978-10-17 | — | — | US | claimed |
| US-4022936-A | COATING WITH A SALICYLIC ACID DERIVATIVE AND A ZINC COMPOUND WITH AMMONIUM HYDROXIDE | NCR CORPORATION (US) | 1977-05-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250332079-A1 | TOPICAL SUNSCREEN | SUN2, CYP51A1, DSG1 | LMNA 2665/4885ALDH1A1 1641/4885CA2 4487/4885 |
| US-20210093529-A1 | TOPICAL SUNSCREEN | SUN2, CYP51A1, DSG1 | LMNA 2665/4885ALDH1A1 1641/4885CA2 4487/4885 |
| US-12350356-B2 | Topical sunscreen | SUN2, CYP51A1, DSG1 | LMNA 2665/4885ALDH1A1 1641/4885CA2 4487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.